TY - JOUR
T1 - Non-surgical Management of Myomas
AU - Laughlin-Tommaso, Shannon K.
N1 - Funding Information:
Dr. Laughlin-Tommaso has received research funding, paid to Mayo Clinic, from InSightec Ltd. (Israel) for a focused ultrasonography ablation clinical trial, is on the Data Safety Monitoring Board for the Uterine Leiomyoma Treatment with Radiofrequency Ablation trial (ULTRA trial, Halt Medical, Inc.), and is on an Advisory Board for Allergan.
Publisher Copyright:
© 2017 American Association of Gynecologic Laparoscopists
PY - 2018/2
Y1 - 2018/2
N2 - Uterine myomas are a common condition and the leading cause of hysterectomy. Clinically, myomas can be challenging because they range from asymptomatic to causing severe, debilitating symptoms and occur in many women before childbearing is complete. Thus, women often seek uterine-conserving and nonsurgical management of their myomas. In this review the available uterine-conserving treatment options from medical management through minimally invasive procedures are discussed. To the extent of research available, the sustainability of symptom improvement and the effects on future fertility are reviewed. Future research may lead to therapies that reduce the risks of major surgery, decrease side effects, and offer primary or secondary prevention options.
AB - Uterine myomas are a common condition and the leading cause of hysterectomy. Clinically, myomas can be challenging because they range from asymptomatic to causing severe, debilitating symptoms and occur in many women before childbearing is complete. Thus, women often seek uterine-conserving and nonsurgical management of their myomas. In this review the available uterine-conserving treatment options from medical management through minimally invasive procedures are discussed. To the extent of research available, the sustainability of symptom improvement and the effects on future fertility are reviewed. Future research may lead to therapies that reduce the risks of major surgery, decrease side effects, and offer primary or secondary prevention options.
KW - Focused ultrasound ablation
KW - Leiomyoma
KW - Myoma
KW - Uterine artery embolization
UR - http://www.scopus.com/inward/record.url?scp=85030182326&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030182326&partnerID=8YFLogxK
U2 - 10.1016/j.jmig.2017.08.642
DO - 10.1016/j.jmig.2017.08.642
M3 - Review article
C2 - 28821471
AN - SCOPUS:85030182326
SN - 1553-4650
VL - 25
SP - 229
EP - 236
JO - Journal of Minimally Invasive Gynecology
JF - Journal of Minimally Invasive Gynecology
IS - 2
ER -